Literature DB >> 8335195

Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis.

E M Zimmermann1, R B Sartor, R D McCall, M Pardo, D Bender, P K Lund.   

Abstract

BACKGROUND: Insulinlike growth factor I (IGF-I) is mitogenic for fibroblasts and smooth muscle cells and stimulates collagen synthesis. The present study tested the hypothesis that IGF-I is important in the development of granulomatous inflammation and fibrosis.
METHODS: IGF-I messenger RNA (mRNA) was measured in bowel and liver of rats with peptidoglycan-polysaccharide-induced chronic granulomatous enterocolitis and hepatitis using RNase protection. Cellular sites of IGF-I mRNA and IGF-I peptide precursor were localized by in situ hybridization and immunohistochemistry, respectively. Sites of IGF-I synthesis were compared with sites of interleukin 1 beta mRNA expression.
RESULTS: IGF-I mRNA was increased 3.7-fold in cecal tissue from peptidoglycan-polysaccharide-injected rats compared with controls. IGF-I mRNA was up-regulated in fibroblastlike cells in the intensely fibrotic periphery of cecal and hepatic granulomas. This region also expressed IGF-I peptide precursor. Interleukin 1 mRNA localized to macrophage-like cells in the center of granulomas.
CONCLUSIONS: IGF-I may be important in the development of fibrosis in this model of Crohn's disease. The localization of IGF-I and interleukin 1 mRNAs to distinct but adjacent sites is consistent with a paracrine interaction between cells expressing IGF-I and interleukin 1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335195     DOI: 10.1016/0016-5085(93)90713-m

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

Review 1.  The role of circulating IGF-I: lessons from human and animal models.

Authors:  Shoshana Yakar; Yiping Wu; Jennifer Setser; Clifford J Rosen
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

2.  Amelioration of excess collagen IαI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice.

Authors:  Sunila Mahavadi; Robert S Flynn; John R Grider; Li-Ya Qiao; Karnam S Murthy; Krystina B Hazelgrove; John F Kuemmerle
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

Review 3.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

4.  Endogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's disease.

Authors:  Robert S Flynn; Karnam S Murthy; John R Grider; John M Kellum; John F Kuemmerle
Journal:  Gastroenterology       Date:  2009-09-12       Impact factor: 22.682

5.  Extraintestinal manifestations of granulomatous enterocolitis induced in rabbits by long-term submucosal administration of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

6.  Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease.

Authors:  Kinan Rahal; Phyllissa Schmiedlin-Ren; Jeremy Adler; Muhammad Dhanani; Victoria Sultani; Ahren C Rittershaus; Laura Reingold; Ji Zhu; Barbara J McKenna; Gregory M Christman; Ellen M Zimmermann
Journal:  Inflamm Bowel Dis       Date:  2011-08-29       Impact factor: 5.325

7.  Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cells.

Authors:  Patricia Garcia; Phyllissa Schmiedlin-Ren; Jason S Mathias; Huaijing Tang; Gregory M Christman; Ellen M Zimmermann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-03       Impact factor: 4.052

8.  Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease.

Authors:  Jeremy Adler; Scott D Swanson; Phyllissa Schmiedlin-Ren; Peter D R Higgins; Christopher P Golembeski; Alexandros D Polydorides; Barbara J McKenna; Hero K Hussain; Trevor M Verrot; Ellen M Zimmermann
Journal:  Radiology       Date:  2011-01-28       Impact factor: 11.105

9.  Anti-TNFα alters the natural history of experimental Crohn's disease in rats when begun early, but not late, in disease.

Authors:  Phyllissa Schmiedlin-Ren; Laura J Reingold; Christopher S Broxson; Ahren C Rittershaus; Josh S Brudi; Jeremy Adler; Scott R Owens; Ellen M Zimmermann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

10.  Endogenous IGF-I and alpha v beta3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis.

Authors:  Krystina B Hazelgrove; Robert S Flynn; Li-Ya Qiao; John R Grider; John F Kuemmerle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.